Gabriel Leung, Director at NovoCure Ltd (NVCR), sold 23,203 shares at $85.00 ($1.9M) on 2019-11-18, disclosed to the SEC on 2019-11-19.
Open-market sale of $1.9M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.52 | 1,700 | $140K | 7.2% |
| 2 | $82.55 | 1,500 | $124K | 6.4% |
| 3 | $83.50 | 2,800 | $234K | 12.0% |
| 4 | $83.51 | 3,203 | $267K | 13.7% |
| 5 | $83.51 | 3,203 | $267K | 13.7% |
| 6 | $84.00 | 354 |
| $30K |
| 1.5% |
| 7 | $84.02 | 443 | $37K | 1.9% |
| 8 | $85.00 | 10,000 | $850K | 43.6% |
| Total | $84.03 avg | 23,203 | $1.9M | 100% |
| Filing → |
| NVCR | SELL | 2024-06-06 | $23K | — | Filing → |
| NVCR | SELL | 2021-08-06 | $153K | — | Filing → |
| NVCR | SELL | 2021-07-08 | $184K | — | Filing → |